Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correcting the record on anemia of aging: a statistical reanalysis.

Blood advances·2023
Same author

COVID-19, nuclear war, and global warming: lessons for our vulnerable world.

Lancet (London, England)·2020
Same author

The Genetic Landscape of Diamond-Blackfan Anemia.

American journal of human genetics·2019
Same author

The Genetic Landscape of Diamond-Blackfan Anemia.

American journal of human genetics·2018
Same author

The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited.

Hematology/oncology clinics of North America·2018
Same author

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.

Blood advances·2018

Related Experiment Video

Updated: May 9, 2026

Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion
09:47

Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion

Published on: June 14, 2024

Hemoglobin disorders: a look to the future.

David G Nathan1

  • 1Dana-Farber Cancer Institute.

Blood
|August 10, 2013
PubMed
Summary
This summary is machine-generated.

This study compares bone marrow and cord blood transplants for severe β thalassemia and sickle cell disease. Results show transplant type impacts outcomes, highlighting the need for careful donor selection in blood stem cell transplantation.

More Related Videos

Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

Related Experiment Videos

Last Updated: May 9, 2026

Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion
09:47

Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion

Published on: June 14, 2024

Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

Area of Science:

  • Hematology
  • Transplantation immunology
  • Pediatric hematology

Background:

  • Severe β thalassemia (SBT) and sickle cell disease (SCD) are debilitating blood disorders requiring stem cell transplantation.
  • Histocompatible family donor bone marrow and cord blood transplants (BMT and CBT) are potential curative options.
  • Advances in MHC typing and supportive care have evolved over the study period.

Purpose of the Study:

  • To compare the outcomes of BMT and CBT from histocompatible family donors for patients with SBT and SCD.
  • To evaluate the impact of evolving medical practices on transplant results between 1994 and 2005.

Main Methods:

  • Retrospective analysis of data from the Eurocord and European Blood and Marrow Transplantation group.
  • Inclusion of data from collaborating centers in the US, Hong Kong, and Israel.
  • Focus on patients with SBT and SCD undergoing BMT or CBT.

Main Results:

  • The study provides a comparative analysis of BMT versus CBT outcomes for SBT and SCD.
  • Identifies key factors influencing transplant success over a decade of evolving medical care.
  • Highlights the complexities of interpreting results from a 'moving target' due to medical advancements.

Conclusions:

  • The findings offer valuable insights into the relative efficacy of BMT and CBT for severe blood disorders.
  • Emphasizes the importance of considering donor source and evolving medical practices in transplant decision-making.
  • Underscores the contribution of collaborative international efforts in advancing transplantation for hematologic diseases.